CS and type 2 diabetes mellitus: Importantly, this decrease in CRLS1 in T2DM patients was not attributable to a general trend in mitochondria-linked gene expression, as mRNA levels of the canonical mitochondrial marker citrate synthase (CS) were unchanged across disease status (Figure 7C).